Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-04
DOI
10.1007/s00262-021-02896-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer
- (2020) Shiyuan Wang et al. BRIEFINGS IN BIOINFORMATICS
- Lung Cancer 2020
- (2020) Brett C. Bade et al. CLINICS IN CHEST MEDICINE
- Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
- (2020) Julieta Afonso et al. Nature Reviews Urology
- Resistance to Checkpoint Inhibition in Cancer Immunotherapy
- (2020) Luisa Barrueto et al. Translational Oncology
- Principles of Immunotherapy in Non-Small Cell Lung Cancer
- (2020) Melinda L. Hsu et al. Thoracic Surgery Clinics
- Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
- (2020) Sijin Sun et al. Cancer Medicine
- Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
- (2020) Furong Liu et al. Experimental Hematology & Oncology
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
- (2019) Xiaoyun Li et al. Nature Reviews Clinical Oncology
- The influence of microenvironment on tumor immunotherapy
- (2019) Jieying Zhang et al. FEBS Journal
- Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
- (2019) Michal Harel et al. CELL
- Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
- (2018) Tina Cascone et al. Cell Metabolism
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer
- (2018) Jiangjiang Li et al. Theranostics
- Identification of an eight-gene prognostic signature for lung adenocarcinoma
- (2018) Shicheng Li et al. Cancer Management and Research
- Altered cancer metabolism in mechanisms of immunotherapy resistance
- (2018) Rishab Ramapriyan et al. PHARMACOLOGY & THERAPEUTICS
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
- (2017) Hawazin Faruki et al. Journal of Thoracic Oncology
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme
- (2017) Giannis Sokratous et al. Human Vaccines & Immunotherapeutics
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
- (2015) Ping-Chih Ho et al. CELL
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
- (2012) Hélène Salmon et al. JOURNAL OF CLINICAL INVESTIGATION
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
- (2011) Richard Possemato et al. NATURE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Immunotherapy for Lung Cancer
- (2010) Penelope A. Bradbury et al. Journal of Thoracic Oncology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started